Safety study of two antibiotics for serious hospital infections
Treatments studied
Part of Infections, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study watches how safely two common antibiotics (vancomycin and a combination called piperacillin/tazobactam) work together in hospitalized patients with serious infections. Researchers want to make sure the combination doesn't harm kidney function.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are currently in the hospital or being admitted to the hospital
- You are 18 years old or older
- You have a serious infection that your doctor thinks needs these two antibiotics together
- We can enroll you before or very early in your antibiotic treatment (before the second dose)
- You have had at least one kidney function test (creatinine) in the past year, plus a baseline test
- You or a legal representative can give informed consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two common antibiotic combinations to see which one is less likely to cause kidney injury in hospitalized patients. You may be eligible if you need treatment with vancomycin plus either piperacillin-tazobactam or cefepime.
This trial compares two common antibiotics, meropenem and piperacillin/tazobactam, to see which works better for adults with sepsis who are critically ill. It aims to help doctors choose the best treatment for serious infections.
This study compares two common antibiotic combinations to see which one is safer for your kidneys. It uses a special blood test (cystatin-C) alongside standard tests to get a clearer picture of kidney function.
This study looks at how a common antibiotic is removed by kidney dialysis in very ill patients. This may help doctors give the right amount to keep the infection under control.
This study compares two ways of giving antibiotics to children with sepsis: the usual short infusions versus longer or continuous infusions. The goal is to see if one approach works better or is safer.
This trial tests whether piperacillin-tazobactam works as well as meropenem to treat bloodstream infections caused by certain E. coli or Klebsiella germs that resist common cephalosporin antibiotics. It may help you avoid a “bigger” antibiotic if the study drug is equally effective.
Hear when a new Acute Kidney Injury trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.